Connect with us

Hi, what are you looking for?

Jewish Business News


Jim Cramer: Ackman Is At It Again

Jim Cramer 640x360On CNBC’s Mad Dash, Jim Cramer discussed Zoetis, an animal health biotech,   that is a “gem of a company” spun off by Pfizer. Even though the company seems to be doing everything right, Bill Ackman has taken an 8.2% stake in the company and is pushing for it to be sold to Valeant. This is a similar case to Ackman’s long-standing campaign to have Valeant take over Allergan in a hostile takeover bid.

Jim Cramer has said many times that activist investors should go after weak companies with challenged management and turn them around rather than trying to shake up a company is performing well. “I don’t know what more they can do, ” Cramer spoke of Zoetis’ management. At $44, Zoetis is likely to go higher on this takeover talk, but he doesn’t sound too enthuses about Ackman’s tactics.







You May Also Like

World News

In the 15th Nov 2015 edition of Israel’s good news, the highlights include:   ·         A new Israeli treatment brings hope to relapsed leukemia...


The Movie The Professional is what made Natalie Portman a Lolita.


After two decades without a rating system in Israel, at the end of 2012 an international tender for hotel rating was published.  Invited to place bids...

VC, Investments

You may not become a millionaire, but there is a lot to learn from George Soros.